SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,756 | +23.1% | 13,096 | 0.0% | 0.00% | – |
| Q4 2023 | $7,115 | -9.4% | 13,096 | 0.0% | 0.00% | – |
| Q3 2023 | $7,855 | -53.9% | 13,096 | 0.0% | 0.00% | – |
| Q2 2023 | $17,025 | -68.8% | 13,096 | -57.8% | 0.00% | – |
| Q1 2023 | $54,584 | -70.9% | 31,013 | -48.0% | 0.00% | – |
| Q4 2022 | $187,351 | -31.6% | 59,666 | +6.7% | 0.00% | – |
| Q3 2022 | $274,000 | +25.7% | 55,922 | +6.6% | 0.00% | – |
| Q2 2022 | $218,000 | -30.4% | 52,447 | -2.6% | 0.00% | – |
| Q1 2022 | $313,000 | -22.7% | 53,860 | -0.4% | 0.00% | – |
| Q4 2021 | $405,000 | -16.5% | 54,091 | +0.5% | 0.00% | – |
| Q3 2021 | $485,000 | +35.9% | 53,820 | +80.0% | 0.00% | – |
| Q2 2021 | $357,000 | -5.1% | 29,908 | -0.2% | 0.00% | – |
| Q1 2021 | $376,000 | -11.7% | 29,956 | +9.8% | 0.00% | – |
| Q4 2020 | $426,000 | +63.8% | 27,272 | -0.6% | 0.00% | – |
| Q3 2020 | $260,000 | -10.3% | 27,441 | -15.1% | 0.00% | – |
| Q2 2020 | $290,000 | +47.2% | 32,308 | +4.7% | 0.00% | – |
| Q1 2020 | $197,000 | -34.6% | 30,866 | -14.2% | 0.00% | – |
| Q4 2019 | $301,000 | +2.0% | 35,985 | +10.2% | 0.00% | – |
| Q3 2019 | $295,000 | +17.1% | 32,655 | +39.4% | 0.00% | – |
| Q2 2019 | $252,000 | +29.2% | 23,425 | +14.6% | 0.00% | – |
| Q1 2019 | $195,000 | -6.2% | 20,445 | +13.2% | 0.00% | – |
| Q4 2018 | $208,000 | -25.7% | 18,066 | +9.3% | 0.00% | – |
| Q3 2018 | $280,000 | +19.1% | 16,532 | 0.0% | 0.00% | – |
| Q2 2018 | $235,000 | -20.1% | 16,532 | +6.8% | 0.00% | – |
| Q1 2018 | $294,000 | -16.9% | 15,483 | -27.5% | 0.00% | – |
| Q4 2017 | $354,000 | +10.3% | 21,358 | -1.5% | 0.00% | – |
| Q3 2017 | $321,000 | +92.2% | 21,677 | +15.5% | 0.00% | – |
| Q2 2017 | $167,000 | +79.6% | 18,774 | 0.0% | 0.00% | – |
| Q1 2017 | $93,000 | +63.2% | 18,774 | 0.0% | 0.00% | – |
| Q4 2016 | $57,000 | -6.6% | 18,774 | +41.5% | 0.00% | – |
| Q3 2016 | $61,000 | -19.7% | 13,267 | 0.0% | 0.00% | – |
| Q2 2016 | $76,000 | -2.6% | 13,267 | 0.0% | 0.00% | – |
| Q1 2016 | $78,000 | -18.8% | 13,267 | +27.3% | 0.00% | – |
| Q4 2015 | $96,000 | +71.4% | 10,419 | 0.0% | 0.00% | – |
| Q3 2015 | $56,000 | -49.5% | 10,419 | 0.0% | 0.00% | – |
| Q2 2015 | $111,000 | -33.1% | 10,419 | 0.0% | 0.00% | – |
| Q1 2015 | $166,000 | +3.8% | 10,419 | 0.0% | 0.00% | – |
| Q4 2014 | $160,000 | +39.1% | 10,419 | 0.0% | 0.00% | – |
| Q3 2014 | $115,000 | – | 10,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |